Indication

Inactive tuberculosis

Inactive tuberculosis, clinically referred to as latent tuberculosis infection (LTBI), is a state of persistent immune containment following infection with *Mycobacterium tuberculosis*. Read more about Inactive tuberculosis

38 drugs 32 manufacturers

Advertisement

Drugs that treat it

Common Inactive tuberculosis therapies.

Showing 19–27 of 38 drugs

RIFAMPIN

RIFAMYCINS·ACTIVE TUBERCULOSIS·+3
APP/FRESENIUS K

ISONIAZID

ISONIAZIDS·PULMONARY TUBERCULOSIS·+4
TEVA USA

ISONIAZID

ISONIAZIDS·PULMONARY TUBERCULOSIS·+4
GSK Consumer Healthcare

RIFAMPIN

RIFAMYCINS·ACTIVE TUBERCULOSIS·+3
EPIC PHARMA LLC

RIFAMPIN

RIFAMYCINS·ACTIVE TUBERCULOSIS·+3
A-S MEDICATION

ISONIAZID

ISONIAZIDS·PULMONARY TUBERCULOSIS·+4
CHARTWELL RX LL

RIFAMPIN

RIFAMYCINS·ACTIVE TUBERCULOSIS·+3
CHARTWELL RX LL

ISONIAZID

ISONIAZIDS·PULMONARY TUBERCULOSIS·+4
BRYANT RANCH PR
Filter & compare in the drug finder →Opens the drug finder with Inactive tuberculosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Inactive tuberculosis.

Inactive tuberculosis, clinically referred to as latent tuberculosis infection (LTBI), is a state of persistent immune containment following infection with *Mycobacterium tuberculosis*.

In this stage, viable mycobacteria are sequestered by the host immune system—predominantly within pulmonary granulomas—without causing clinical illness or active tissue destruction.

Patients with inactive tuberculosis are entirely asymptomatic, noncontagious, and demonstrate normal chest radiography alongside negative microbiological evaluations, though they exhibit immunological sensitization via a positive tuberculin skin test or interferon-gamma release assay.

Although contained, dormant bacilli represent a lifelong reservoir that can reactivate into active, transmissible tuberculosis disease, particularly in individuals who develop cellular immunosuppression.

Personalize your experience

Follow Inactive tuberculosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it